Searched for: in-biosketch:yes
person:levanm01
Landscape Of Post-Donation Follow-up of Living Kidney Donors in the United States, 2013-2023
Reed, Rhiannon D; Xue, Ruiqi; Thomas, Alvin G; Akhtar, Jasmine; Menon, Gayathri; Weiss, Samantha; Segev, Dorry L; Stewart, Darren E; Orandi, Babak J; Ali, Nicole M; Stern, Jeffrey M; Massie, Allan B; Levan, Macey L
Post-donation follow-up is critical for living kidney donor (LKD) care, facilitating early detection of unusual decrease in renal function and providing opportunities for early intervention. Herein, we update and characterize temporal trends in LKD follow-up (LDF) using Organ Procurement and Transplantation Network data. We identified 64,488 LKDs (2/2013-12/2023) and used logistic regression to assess donor characteristics associated with complete and timely (defined per current OPTN policy) LDF at 6-months, 1-year and 2-years post-donation. The proportion of complete and timely LDF submissions was generally consistent since 2013 for clinical and laboratory data at each time point. Overall, complete and timely 6-month, 1-year, and 2-year LDF were 84%, 81% and 75% for clinical data, and 80%, 75% and 68% for laboratory data. Across all time points, LKDs with pre-donation BMI≥30, Black race, and of younger age had higher odds of incomplete follow-up. We also observed substantial center-level variation, with the proportion of transplant centers meeting 6-month LDF thresholds ranging from 56-81% each year. In this retrospective registry analysis, LDF remained suboptimal and varied by center and donor characteristics, demonstrating the need for targeted approaches to improve LDF, particularly among those at increased risk of kidney disease or facing barriers to care.
PMID: 43003187
ISSN: 1600-6143
CID: 6075739
Landscape Of Post-Donation Follow-up of Living Kidney Donors in the United States, 2013-2023
Reed, Rhiannon D; Xue, Ruiqi; Thomas, Alvin G; Akhtar, Jasmine; Menon, Gayathri; Weiss, Samantha; Segev, Dorry L; Stewart, Darren E; Orandi, Babak J; Ali, Nicole M; Stern, Jeffrey M; Massie, Allan B; Levan, Macey L
Post-donation follow-up is critical for living kidney donor (LKD) care, facilitating early detection of unusual decrease in renal function and providing opportunities for early intervention. Herein, we update and characterize temporal trends in LKD follow-up (LDF) using Organ Procurement and Transplantation Network data. We identified 64,488 LKDs (2/2013-12/2023) and used logistic regression to assess donor characteristics associated with complete and timely (defined per current OPTN policy) LDF at 6-months, 1-year and 2-years post-donation. The proportion of complete and timely LDF submissions was generally consistent since 2013 for clinical and laboratory data at each time point. Overall, complete and timely 6-month, 1-year, and 2-year LDF were 84%, 81% and 75% for clinical data, and 80%, 75% and 68% for laboratory data. Across all time points, LKDs with pre-donation BMI≥30, Black race, and of younger age had higher odds of incomplete follow-up. We also observed substantial center-level variation, with the proportion of transplant centers meeting 6-month LDF thresholds ranging from 56-81% each year. In this retrospective registry analysis, LDF remained suboptimal and varied by center and donor characteristics, demonstrating the need for targeted approaches to improve LDF, particularly among those at increased risk of kidney disease or facing barriers to care.
PMID: 43003187
ISSN: 1600-6143
CID: 6075741
Landscape Of Post-Donation Follow-up of Living Kidney Donors in the United States, 2013-2023
Reed, Rhiannon D; Xue, Ruiqi; Thomas, Alvin G; Akhtar, Jasmine; Menon, Gayathri; Weiss, Samantha; Segev, Dorry L; Stewart, Darren E; Orandi, Babak J; Ali, Nicole M; Stern, Jeffrey M; Massie, Allan B; Levan, Macey L
Post-donation follow-up is critical for living kidney donor (LKD) care, facilitating early detection of unusual decrease in renal function and providing opportunities for early intervention. Herein, we update and characterize temporal trends in LKD follow-up (LDF) using Organ Procurement and Transplantation Network data. We identified 64,488 LKDs (2/2013-12/2023) and used logistic regression to assess donor characteristics associated with complete and timely (defined per current OPTN policy) LDF at 6-months, 1-year and 2-years post-donation. The proportion of complete and timely LDF submissions was generally consistent since 2013 for clinical and laboratory data at each time point. Overall, complete and timely 6-month, 1-year, and 2-year LDF were 84%, 81% and 75% for clinical data, and 80%, 75% and 68% for laboratory data. Across all time points, LKDs with pre-donation BMI≥30, Black race, and of younger age had higher odds of incomplete follow-up. We also observed substantial center-level variation, with the proportion of transplant centers meeting 6-month LDF thresholds ranging from 56-81% each year. In this retrospective registry analysis, LDF remained suboptimal and varied by center and donor characteristics, demonstrating the need for targeted approaches to improve LDF, particularly among those at increased risk of kidney disease or facing barriers to care.
PMID: 43003187
ISSN: 1600-6143
CID: 6075740
Clinical Profiles and Early Outcomes of Living Kidney Donors With Pre-Existing Type 2 Diabetes
Lonze, Bonnie E; Husain, Syed Ali; Newsome, Jacey B; Thakur, Madhur; Weiss, Samantha A; Ali, Nicole M; Levan, Macey L; Thomas, Alvin G; Orandi, Babak J; Reed, Rhiannon D; Massie, Allan B; Segev, Dorry L; Stewart, Darren E
INTRODUCTION:In 2022, Organ Procurement and Transplantation Network policy was revised to permit living kidney donation by carefully selected individuals with type 2 diabetes mellitus (T2DM), which had previously been prohibited. Early evaluation is needed to understand adoption of this practice and short-term donor outcomes. METHODS:, and proteinuria. RESULTS:, (p = 0.12), and proteinuria was present in 12% of T2DM donors vs. 7% (p = 0.23). CONCLUSIONS:Living kidney donation by individuals with T2DM is uncommon but increasing. Though differences in early outcomes for T2DM vs. non-T2DM donors were not statistically significant, these null findings are based on small sample sizes and should not be interpreted as evidence of long-term safety. Careful donor selection and longer-term follow-up are needed to better define donor risk.
PMID: 42927437
ISSN: 1399-0012
CID: 6074713
State Medicaid Body Mass Index Requirements for Solid Organ Transplant Coverage: A 50-State Policy Review
Klitenic, Samantha B; Sullivan, Brigitte; Boulton, Gabriella; McBride, Jennifer; Massie, Allan B; Segev, Dorry L; Levan, Macey L; Orandi, Babak J
INTRODUCTION/BACKGROUND:Body mass index (BMI) has long served as a screening tool for assessing procedural risk and is used as an exclusion criterion for insurance coverage. Variation in state Medicaid policies, specifically pre-transplant BMI requirements, may affect transplant eligibility and limit access to transplantation. No published literature summarizes these policies. We conducted a 50-state review of Medicaid policies to identify pre-transplant BMI requirements across solid organ transplantation (heart, lung, liver, kidney, pancreas, intestine). METHODS:Public records requests were submitted to state Medicaid offices for relevant policy documents. Policies were categorized as: (1) Restrictive: precludes transplant coverage if a specified weight/BMI cutoff is not met; (2) Somewhat restrictive: no explicit BMI requirements but deference to managed care organization (MCO)/transplant center criteria; or (3) Unrestrictive: no BMI requirements or publicly available MCO/transplant center criteria. RESULTS:Three states (HI, IA, and NC) had restrictive policies with pre-transplant weight/BMI requirements for coverage of heart, lung, and combined heart-lung transplants. None applied to kidney, liver, pancreas, or intestine transplants. Thirty-two states and DC had somewhat restrictive policies; 15 had unrestrictive policies. CONCLUSIONS:Most state Medicaid policies do not contain explicit BMI eligibility requirements for transplant coverage. Instead, BMI-based criteria typically originate from MCOs/transplant centers that establish and enforce their own criteria.
PMID: 42829945
ISSN: 1399-0012
CID: 6073875
Reply to Comment on "Beyond theory and into practice: A qualitative study of the experiences of xenotransplant recipients" [Letter]
Levan, Macey L; Reed, Rhiannon D
PMID: 42785588
ISSN: 1600-6143
CID: 6073565
Early Changes in Kidney Transplantation following Implementation of the Increasing Organ Transplant Access Model
Husain, Syed Ali; Levan, Macey L; Thakur, Madhur; Reed, Rhiannon D; Locke, Jayme E; Weiss, Samantha A; Massie, Allan B; Segev, Dorry L; Stewart, Darren E
BACKGROUND:The Increasing Organ Transplant Access (IOTA) model is a mandatory experimental payment model that aims to improve kidney transplant access using financial incentives and penalties for transplant centers randomized to model participation, based primarily on growth in transplant volume. METHODS:We used national transplant registry data to conduct a retrospective cohort study of US kidney transplant centers. We identified centers randomized to IOTA participation based on the published list of center participants. Using a difference-in-differences approach, we compared IOTA participants to non-participants on changes in overall, deceased donor, and living donor kidney transplant volume per 30 days in the period before IOTA randomization status was announced versus the 9 months following IOTA implementation. Separately among IOTA participants and among non-participants, we compared the proportional change in transplant volume when stratifying centers by pre-IOTA transplant volume, organ offer acceptance rate, and transplant rate ratio. RESULTS:Among 177 included centers, 97 (55%) were IOTA participants and 80 (45%) non-participants. Most IOTA participants (53%) and non-participants (55%) experienced a fall in overall transplant volume after model implementation. However, IOTA participants exhibited a 5% increase in transplant volume per 30 days, whereas non-participants exhibited a 3% decrease (P=0.01). The difference between groups was seen for deceased donor transplants (participants +5% vs. non-participants -9%, P<0.001), while living donor transplants rose in both groups (+7 vs. +19%, P=0.24). Among IOTA participants, there were no statistically significant differences in changes in transplant volume when comparing centers categorized by pre-IOTA transplant volume, organ offer acceptance rate, or transplant rate ratio. CONCLUSIONS:Centers randomized to IOTA participation outperformed model non-participants in changes in kidney transplant volume after model implementation, driven by an increase in deceased donor transplant volume among model participants but a fall among non-participants.
PMID: 42758550
ISSN: 1555-905x
CID: 6072957
Temporal Changes in the Recovery and Utilization of Kidneys Donated After Circulatory Death in the United States
Husain, Syed Ali; Zeiser, Laura; Ishaque, Tanveen; Orandi, Babak J; Levan, Macey L; Stern, Jeffrey M; Motter, Jennifer D; Lonze, Bonnie E; Coons, Barbara E; Lipton, Marissa K; Sommer, Philip M; Bae, Sunjae; Parent, Brendan; Segev, Dorry L; Massie, Allan B; Stewart, Darren E
Kidneys from donation after circulatory death (DCD) donors historically had lower recovery and utilization than kidneys from donation after brain death (DBD) donors. However, the organ shortage and advances in organ preservation have increased interest in DCD transplantation. We used OPTN data to study temporal changes in U.S. DCD kidney recovery and transplantation. The percent DCD among kidney donors increased from 21.0% (Era1: 2016-2019) to 30.6% (Era2: 2020-2022) and 42.4% (Era3: 2023-2025). By 2025Q2, more than half (50.4%) of kidney donors were DCDs. Wide variability persisted across eras in percent DCD by recovering OPO (Era1 range: 0%-38%, Era2: 0%-49%, Era3: 0.4%-60%) and by transplanting center (Era1 range: 0%-48%, Era2: 0%-58%, Era3: 0%-60%). Transplanted DCD kidneys in Era3 (vs Era1 & Era2) were more likely to have donor age >60, diabetes, hypertension, obesity, and death due to cardiovascular disease or stroke; 86.8% were pumped. Though the recovered DCD kidney nonuse rate rose from 20.8% (Era1) to 29.9% (Era2) and 35.4% (Era3), nonused DCD kidney donors were age and had more comorbidities in Era 3 compared to earlier eras. Given that half of kidney donors are now DCD, refinements in DCD donor selection and management are needed to optimize recovery and utilization.
PMID: 42722333
ISSN: 1600-6143
CID: 6072263
Defending Principled Advocacy for Children in Modern Organ Transplant [Letter]
Husain, Syed Ali; Ovchinsky, Nadia; Goldstein, Matthew; Levan, Macey L
PMID: 42638585
ISSN: 1399-3046
CID: 6071763
Organ Procurement Organization Perspectives on Normothermic Regional Perfusion Practices: A Qualitative Interview Study
Kaplow, Katya; Buster, Amanda; Gordon, Elisa J; Wall, Anji E; Flower, Tessa; Sidoti, Carolyn N; Levan, Macey L; Parent, Brendan
BACKGROUND/UNASSIGNED:Normothermic regional perfusion (NRP) increases the availability of quality transplantable organs. However, there are unresolved ethical challenges and variability in approaches to NRP facilitation across U.S. organ procurement organizations (OPOs). We sought to assess the landscape of OPO member perceptions on facilitating NRP. METHODS/UNASSIGNED:Semi-structured interviews with OPO executives assessed their experiences collaborating with hospital partners, communicating with donor families, and training hospital personnel to implement NRP. Qualitative themes were elicited through deductive and inductive thematic content analysis. RESULTS/UNASSIGNED:Twenty executives participated (53% participation rate). Five themes emerged: 1) comfort with allowing NRP procedures varied across and within donor hospitals and recipient transplant centers; 2) most participating OPOs lacked standardized operating procedures regarding case protocols and data collection protocols for NRP cases; 3) OPOs disclosed varied information about NRP during authorization conversations with donor families; 4) OPOs collaborated with donor hospitals and recipient transplant centers before, during, and after NRP cases; and 5) OPOs engaged in proactive educational efforts about NRP with partner hospitals before NRP cases are presented. CONCLUSIONS/UNASSIGNED:Our findings suggest that proactive, consistent, and cross-organization collaboration may help hospitals decide whether and how to adopt NRP and may help OPOs more effectively address challenges regarding the implementation of NRP. Future research should empirically assess NRP-related OPO practices.
PMCID:13502116
PMID: 42616650
ISSN: 2329-4523
CID: 6071475